The latest research study “Large Volume Parenteral (LVP) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global large volume parenteral (LVP) market reached a value of US$ 8.58 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 12.9 Billion by 2027, exhibiting a CAGR of 6.50% during 2022-2027.
A large volume parenteral (LVP) refers to the single-dose injection packaged in a glass bottle or a flexible container of more than 100ml capacity after sterilization via heat. It is injected through the skin or other external boundary tissue to directly administrate the active drug substances into the blood vessels, tissues, lesions, etc. A large volume parenteral generally consists of a water-miscible or non-aqueous vehicle, active ingredient, and added substances, such as antioxidants, buffers, preservatives, surfactants, antimicrobial agents, tonicity adjusters, etc. Some of the commonly available LVPs include irrigating solutions, peritoneal dialysis, blood derivatives, drug premixes, contrast agents, etc.
Request for a Free Sample Copy of This Report: https://www.imarcgroup.com/large-volume-parenteral-market/requestsample
Large Volume Parenteral (LVP) Market Trends:
The widespread product adoption in administering essential nutrients to patients undergoing treatment for gastrointestinal (GI) diseases, esophageal obstruction, cancer, ulcer, etc., is primarily driving the large volume parenteral market. Additionally, the growing prevalence of non-communicable diseases, such as hypertension, diabetes, obesity, and other metabolic disorders is augmenting the demand for LVPs that are a mixture of dextrose, amino acids, lipids, added electrolytes, trace metals, vitamins, etc.
This, in turn, is further catalyzing the market growth. Besides this, the rising utilization of large volume parenteral in heart surgery for preventing ischemic injury to the myocardium during reperfusion and the blood flow supply restriction is acting as another significant growth-inducing factor. Moreover, the inflating need for fast, safe, and effective methods of drug administration among individuals enduring surgical interventions is anticipated to fuel the large volume parenteral market over the forecasted period.
Large Volume Parenteral (LVP) Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Major Players Covered:
- Albert David Ltd.
- B. Braun Melsungen AG
- Grifols S.A
- Otsuka Pharmaceutical Co. Ltd
- Pharmaceutical Solutions Industry Ltd.
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Baxter International Inc.
- BML Parenteral Drugs
- Fresenius Kabi AG
- Thermo Fisher Scientific Inc.
Key Market Segmentation:
The report has segmented the market on the basis of type, volume, application, end users and region.
Breakup by Type:
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
Breakup by Volume:
- 100 ML – 250 ML
- 250 ML – 500 ML
- 500 ML – 1000 ML
- 1000 ML – 2000 ML
- 2000 ML and More
Breakup by Application:
- Therapeutic Injections
- Fluid Balance Injections
- Nutritious Injections
Breakup by End Users:
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Click here to view detailed information with table of content: https://www.imarcgroup.com/large-volume-parenteral-market
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Company Name: IMARC Group
Contact Person: Elena Anderson
Address: 134 N 4th St.
Country: United States